As shown in Figure 2, ERBB2 overexpression led to moderate increases in growth rates for all of the three human prostate cancer cell lines: an average of 43% increase for LnCaP cells, 33% increase for DU145 cells, and 25% increase for PC3 cells. Here, ERBB2 is linked to prostate carcinoma.